Company intelligence / Profile preview

Aleor Dermaceuticals Limited

Vadodara (Karakhadi), Gujarat, Indiaindiafilings.com ↗

Ownership: Private
Employees: ~250
Development stage: Commercial

Overview

Aleor Dermaceuticals has conducted clinical trials for tretinoin cream (0.025% and 0.1%) and adapalene gel (0.3%) for treating acne vulgaris. The company has a US FDA-inspected manufacturing facility in Gujarat, India, and sells its products in the US market.

Therapeutic areas: Dermatology
Modalities: Topical formulationscreamsgelsointmentsshampooslotionssolutionsspraysfoamsmicrosponge and nanoparticulate platform-based products
Industry: Biotech

Drug pipeline

5 assets

clobetasol

Commercial

Indications: Dermatological conditions

4 more assets in the full pipeline.

Request access →

Partnerships

Joint venture with Orbicular Pharmaceutical Technologies Private Ltd (until acquisition by Alembic)

Beyond the preview

Go deeper on Aleor Dermaceuticals Limited.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Aleor Dermaceuticals Limited.

Explore the full profile